Board of Directors

Officers

  • President

    Peter P. Yu, MD, FASCO

    Palo Alto Medical Foundation
    Board Term: 2014-2015
    Specialty: Medical Oncology / Hematology

    Peter P. Yu, MD, FASCO, is a medical oncologist and hematologist and Director of Cancer Research at Palo Alto Medical Foundation, where he worked since 1989. In addition to his role as the 2014-2015 President of ASCO, Dr. Yu also serves on the Scientific Program, Nominating, Government Relations, and Special Awards Selection Committees.

    Bio
  • President-Elect

    Julie M. Vose, MD, MBA, FASCO

    University of Nebraska Medical Center and Fred and Pamela Buffet Cancer Center
    Board Term: 2014-2015
    Speciality: Oncology/Hematology

    Julie M. Vose, MD, MBA, FASCO is the Neumann M. and Mildred E. Harris Professorial Chair and Chief of the Oncology/Hematology Division in the Department of Internal Medicine at the University of Nebraska Medical Center. She is the Associate Director of Clinical Research and Co-Chair of the Lymphoma Program at the Fred and Pamela Buffet Cancer Center. In addition to being ASCO’s President-Elect, Dr. Vose also serves on the Special Awards Selection and Health Disparities Committees.

    Bio
  • Past President

    Clifford A. Hudis, MD, FACP

    Memorial Sloan Kettering Cancer Center
    Board Term: 2014-2015
    Specialty: Breast Cancer

    Clifford A. Hudis, MD, FACP, is Chief of the Breast Cancer Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center, and a professor in the Department of Medicine at Weill Cornell Medical College. In addition to being ASCO’s Immediate Past President, Dr. Hudis currently serves on the Special Awards Selection, Finance, and CancerLinQ Advisory Committees.  His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies.

    Bio
  • Treasurer

    Susan L. Cohn, MD

    University of Chicago
    Board Term: 2012-2015
    Board Seat: Pediatric Oncologist

    Susan L. Cohn, MD, is Director of Clinical Sciences, Section of Pediatric Oncology/Hematology, at Comer Children’s Hospital at The University of Chicago, and a professor of pediatrics at The University of Chicago. In addition to being the Treasurer for ASCO’s Board of Directors, Dr. Cohn also serves on the Finance, Bylaws, and Audit Committees and ASCO Connection Editorial Board. Her research interests include pediatric cancers, particularly neuroblastoma, and blood diseases. She is one of a few pediatric oncologists conducting phase I clinical trials of treatments for neuroblastoma.

    Bio
  • ASCO CEO and CCF CEO (ex-officio)

    Allen S. Lichter, MD, FASCO

    Board Term: 2006-2016
    Specialty: Radiation Oncology

    Allen S. Lichter, MD, FASCO, is the Chief Executive Officer of the American Society of Clinical Oncology and the Conquer Cancer Foundation of ASCO. He has been an ASCO member since 1980 and served the Society in an array of volunteer positions before accepting the position of CEO in 2006. Dr. Lichter’s research and development of three-dimensional treatment planning led to a Gold Medal from the American Society for Radiation Oncology. In 2002, he was elected to membership in the Institute of Medicine of the National Academies of Science.

    Bio

Board Members

  • Smita Bhatia, MD, MPH

    City of Hope Comprehensive Cancer Center
    Board Term: 2012-2016
    Board Seat: Pediatric Oncologist

  • Charles David Blanke, MD, FACP, FASCO

    Oregon Health & Science University Knight Cancer Institute
    Board Term: 2014-2018
    Board Seat: Undesignated Specialty

  • Linda D. Bosserman, MD, FACP

    Wilshire Oncology Medical Group, Inc
    Board Term: 2014-2018
    Board Seat: Community Oncologist

  • Walter J. Curran, Jr., MD

    Winship Cancer Institute of Emory University
    Board Term: 2014-2018
    Board Seat: Radiation Oncologist

  • Stephen S. Grubbs, MD

    Medical Oncology Hematology Consultants, PA
    Board Term: 2012-2015
    Board Seat: Community Oncologist

  • Paulo M. G. Hoff, MD, PhD, FACP

    ICESP—Instituto do Câncer do Estado de São Paulo
    Board Term: 2013-2017
    Board Seat: Undesignated Specialty

  • Hagop M. Kantarjian, MD

    University of Texas M. D. Anderson Cancer Center
    Board Term: 2012-2016
    Board Seat: Undesignated Specialty

  • David Khayat, MD, PhD, FASCO

    Pitié-Salpêtrière Hospital
    Board Term: 2014-2018
    Board Seat: International Oncologist

  • Gary H. Lyman, MD, MPH, FACP, FRCP (Edin), FASCO

    Hutchinson Institute for Cancer Outcomes Research
    Board Term: 2012-2016
    Board Seat: Undesignated Specialty

  • Neal J. Meropol, MD, FASCO

    University Hospitals Case Medical Center & Case Western Reserve University
    Board Term: 2013-2017
    Board Seat: Medical Oncologist

  • Therese M. Mulvey, MD, FASCO

    Southcoast Centers for Cancer Care
    Board Term: 2013-2017
    Board Seat: Community Oncologist

  • W. Charles Penley, MD, FASCO

    Tennessee Oncology, PLLC
    Board Term: 2013-2014
    Board Seat: Conquer Cancer Foundation

  • Carolyn D. Runowicz, MD, FASCO

    Florida International University
    Board Term: 2011-2015
    Board Seat: Surgical Oncologist

  • Lillian L. Siu, MD, FRCPC

    Princess Margaret Hospital/University of Toronto
    Board Term: 2012-2016
    Board Seat: International Oncologist

  • Eric P. Winer, MD, FASCO

    Dana-Farber Cancer Institute
    Board Term: 2011-2015
    Board Seat: Undesignated Specialty